Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice changes in body odour, breath, urine, or even their perception of how food smells after starting Wegovy. These observations are real and worth taking seriously, but most can be explained by the physiology of rapid weight loss and the way semaglutide changes how your digestive system works. Wegovy is a prescription-only medicine; a prescriber assesses whether it is suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've started Wegovy and noticed something different about how you smell, or how the world around you smells, you're not imagining it. This is one of those questions our prescribers hear fairly regularly, often with a note of embarrassment attached. There's no need for that. Smell changes during significant weight loss are a well-documented physiological event, and understanding what's behind them helps you decide whether to monitor quietly, adjust something practical, or flag it to a clinician.
The useful framework here is to separate three distinct phenomena: changes in how you smell (body odour, breath), changes in what comes out of you (urine, flatulence, stool), and changes in how you perceive smell. Each has a different driver. The Wegovy treatment overview on our site covers the broader profile of the medicine, but this page focuses specifically on the sensory side effects that search engines rarely explain clearly.
None of these phenomena necessarily means something has gone wrong. Most settle as your body adapts. A small number of smell-related experiences can, however, point to something worth acting on, so it is worth going through each one carefully.
Wegovy reduces appetite substantially. For many people, this means eating considerably less, sometimes without planning to. When calorie intake drops sharply, the body increasingly turns to fat stores for energy, producing ketone bodies as a byproduct. Ketones are exhaled through the lungs and secreted in sweat. The result can be a faintly sweet or acetone-like smell on the breath or skin, sometimes described as fruity or slightly chemical.
This is not unique to semaglutide. It happens with any calorie deficit large enough to drive meaningful fat metabolism. The semaglutide information page explains how the medicine works at a biological level, including its effect on appetite signalling. If the breath smell troubles you, staying well hydrated and eating adequate protein can help the body process ketones more efficiently. Persistent or very strong acetone breath that accompanies nausea, confusion, or vomiting warrants a call to your prescriber or GP, as those symptoms together occasionally signal a different metabolic state requiring assessment.
The NHS patient information for semaglutide confirms that digestive side effects are the most commonly reported, and altered breath odour sits within that broader picture of GI system change. Increasing water intake, maintaining good oral hygiene, and not skipping meals entirely are practical first steps.
Semaglutide slows gastric emptying. Food moves through the digestive tract more gradually, which changes the timing and nature of fermentation in the gut. More fermentation time means more gas production from gut bacteria, and that gas can be more pungent than usual. Questions about Wegovy-related flatulence come up regularly, and the mechanism is genuinely physiological rather than imagined.
Urine smell shifts are usually ketone-related, as described above, but dehydration compounds this. Wegovy can cause nausea and vomiting, especially early in treatment or after a dose step-up. If fluid intake drops as a result, urine becomes more concentrated and stronger-smelling. More detail on Wegovy and urine smell changes is available if this is your main concern. The practical answer is the same: prioritise fluids, especially water, and let your prescriber know if nausea is severe enough to prevent you drinking adequately.
Dietary choices also matter here. People on Wegovy who increase their vegetable intake in line with clinical guidance around adequate fibre may notice more gas initially. The gut microbiome adjusts, but it takes a few weeks. Reducing high-FODMAP foods temporarily can help, and a discussion with a dietitian is worthwhile if the problem persists.
A separate category of experience involves not how you smell to others, but how smells register to you. Some people on GLP-1 medicines report that food smells more intense, or that previously appealing aromas now trigger nausea. Others describe a general heightening of olfactory sensitivity. The relationship between semaglutide and sense of smell is an emerging area of interest; GLP-1 receptors are present in brain regions involved in sensory processing, and researchers are still working out the implications.
There is also a related question about whether the medicine itself has a smell that some people find unpleasant. This is occasionally reported and is separate from any change in body chemistry. If you have questions about the injection itself or other aspects of starting treatment, the frequently asked questions section covers a range of practical topics.
For the broader context of smell changes linked to semaglutide across both injection and oral forms, the semaglutide and smell page draws these threads together. If you're at the stage of weighing up whether Wegovy is the right option for you, the weight-loss treatments overview outlines how the different licensed medicines compare and what the clinical assessment process involves.
If you decide you want to explore treatment properly, a prescriber can discuss your specific situation in detail. Start your free consultation at our weight-loss treatments page, where a GPhC-registered prescriber reviews your information the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.